Lite Strategy, Inc. (LITS)
NCM · Common · CUSIP 55279B301
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for LITS and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
55279B301 (prev. 55279B202 )
Market Cap
Micro Cap
Previous Symbol
MEIP (changed 9/10/2025)
Previous Name
MEI Pharma, Inc.
Business: Lite Strategy, Inc. is the first U.S. publicly traded company to adopt Litecoin as its primary reserve asset. The Company has expanded beyond being an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism.
Notes: MEI Pharma, Inc. (Nasdaq: MEIP), a clinical-stage pharmaceutical company focused on advancing new therapies for cancer, today announced that its board of directors approved a 1-for-20 reverse stock split. The Company’s common stock will open for trading on the Nasdaq Capital Market on Monday, April 17, 2023 on a split-adjusted basis under the current trading symbol "MEIP." <p> December 19, 2012, Stock Split terms:1 for 6

Company Contact

CEO
Justin J. File Justin J. File
CFO
Justin J. File
Headquarters
11455 El Camino Real, San Diego, CA 92130
Phone
858-369-7100
Investor Relations
Justin J. File · 858-369-7199 · investor@litestrategy.com
SEC EDGAR Filings
View filings »